Patents by Inventor Simon Timothy Bedford

Simon Timothy Bedford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
    Patent number: 9675594
    Abstract: The present invention is directed to arylpyrrolopyridine derivatives of Formula A: The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease or cancer.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: June 13, 2017
    Assignee: H. Lundbeck A/S
    Inventors: Simon Timothy Bedford, I-Jen Chen, Yikang Wang, Douglas Stewart Williamson
  • Arylpyrrolopyridine Derived Compounds as LRRK2 Inhibitors
    Publication number: 20170020850
    Abstract: The present invention is directed to arylpyrrolopyridine derivatives of Formula A: The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease or cancer.
    Type: Application
    Filed: October 7, 2016
    Publication date: January 26, 2017
    Applicants: H. Lundebck A/S, Vernalis (R&D) Ltd.
    Inventors: Simon Timothy Bedford, I-Jen Chen, Yikang Wang, Douglas Stewart Williamson
  • Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
    Patent number: 9499542
    Abstract: The present invention is directed to arylpyrrolopyridine derivatives of formula (A) (A). The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease cancer.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: November 22, 2016
    Assignees: H. Lundbeck A/S, Vernalis (R&D) Ltd.
    Inventors: Simon Timothy Bedford, I-Jen Chen, Yikang Wang, Douglas Stewart Williamson
  • Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
    Publication number: 20160102089
    Abstract: The present invention is directed to arylpyrrolopyridine derivatives of formula (A) (A). The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease cancer.
    Type: Application
    Filed: April 14, 2014
    Publication date: April 14, 2016
    Applicants: H. Lundbeck A/S, Vernalis (R&D) Ltd.
    Inventors: Simon Timothy Bedford, I-Jen Chen, Yikang Wang, Douglas Stewart Williamson
  • Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
    Publication number: 20140315901
    Abstract: The present invention is directed to arylpyrrolopyridine derivatives of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease or cancer.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 23, 2014
    Inventors: Simon Timothy Bedford, I-Jen Chen, Yikang Wang, Douglas Stewart Williamson